FDA Inspection 1021264 — Kentucky Blood Center Inc

Kentucky Blood Center Inc — FEI 1070402

The FDA completed an inspection of Kentucky Blood Center Inc on July 28, 2017 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 28, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lexington, KY (United States)